A prediction model for identifying high-risk lymph node metastasis in clinical low-risk papillary thyroid microcarcinoma

BMC Endocr Disord. 2023 Nov 27;23(1):260. doi: 10.1186/s12902-023-01521-0.

Abstract

Background: The presence of high-volume lymph node metastasis (LNM) and extranodal extension (ENE) greatly increases the risk of recurrence in patients with low-risk papillary thyroid microcarcinoma (PTMC). The goal of this research was to analyze the factors that contribute to high-risk lymph node metastasis in patients with low-risk PTMC.

Methods: We analyzed the records of 7344 patients who were diagnosed with low-risk PTMC and treated at our center from January 2013 to June 2018.LNM with a high volume or ENE was classified as high-risk lymph node metastasis (hr-LNM). A logistic regression analysis was conducted to identify the risk factors associated with hr-LNM. A nomogram was created and verified using risk factors obtained from LASSO regression analysis, to predict the likelihood of hr-LNM.

Results: The rate of hr-LNM was 6.5%. LASSO regression revealed six variables that independently contribute to hr-LNM: sex, age, tumor size, tumor location, Hashimoto's thyroiditis (HT), and microscopic capsular invasion. A predictive nomogram was developed by integrating these risk factors, demonstrating its excellent performance. Upon analyzing the receiver operating characteristic (ROC) curve for predicting hr-LNM, it was observed that the area under the curve (AUC) had a value of 0.745 and 0.730 in the training and testing groups showed strong agreement, affirming great reliability.

Conclusion: Sex, age, tumor size, tumor location, HT, and microscopic capsular invasion were determined to be key factors associated with hr-LNM in low-risk PTMC. Utilizing these factors, a nomogram was developed to evaluate the risk of hr-LNM in patients with low-risk PTMC.

Keywords: Extranodal extension; High volume lymph node Metastasis; Nomogram; Papillary thyroid microcarcinoma; Risk factors.

MeSH terms

  • Carcinoma, Papillary* / secondary
  • Hashimoto Disease* / pathology
  • Humans
  • Lymph Nodes / pathology
  • Lymphatic Metastasis / pathology
  • Reproducibility of Results
  • Retrospective Studies
  • Risk Factors
  • Thyroid Neoplasms* / diagnosis
  • Thyroid Neoplasms* / pathology
  • Thyroid Neoplasms* / surgery

Supplementary concepts

  • Papillary Thyroid Microcarcinoma